Role of androgens in abiraterone resistance.
Giuseppe
G
Colloca
D000737:Androstenols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D011944:Receptors, Androgen / Q000378:metabolism*
D000737:Androstenols; D056572:Histone Deacetylase Inhibitors; D011944:Receptors, Androgen